The effect of noradrenergic drugs on the recovery of walking after spinal cord injury

Spinal Cord

Volumn 41, Issue 3, 2003, Pages 137-143

  Barbeau, H ^a,b,d   Norman, K E ^c  

^a MCGILL UNIVERSITY   (Canada)

^b Jewish Rehab Research Centre   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Clonidine; Reflexes; Spinal cord injuries; Walking

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; SPASMOLYTIC AGENT;

CHRONIC DISEASE; DISEASE SEVERITY; DRUG EFFECT; FLEXOR REFLEX; HUMAN; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; TREADMILL; TREATMENT OUTCOME; WALKING; WALKING SPEED;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CLONIDINE; ELECTROMYOGRAPHY; HUMANS; MOTOR ACTIVITY; NOREPINEPHRINE; SPINAL CORD INJURIES; WALKING;

EID: 0037343435     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3101374     Document Type: Review

References (27)

1. Botterell EH et al. A model for the future care of acute spinal cord injuries. Can J Neurol Sci 1975; 2: 361-380.
2. Gjone R, Nordlse L. Incidence of traumatic paraplegia and tetraplegia in Norway: a statistical survey of the years 1974 and 1975. Paraplegia 1978; 16: 88-93.
3. Kraus JF. Injury of the head and spinal cord: the epidemiological relevance of the medical literature published from 1960 to 1978. J Neurosurg 1980; 53 Suppl: S3-S10.
4. Kurtzke JR. Epidemiology of spinal cord injury. Exp Neurol 1975; 48: 163-236.
5. Minaire P et al. Epidemiology of spinal cord injury in the Rhones-Alps region, France, 1970-1975. Paraplegia 1978; 16: 76-87.
6. Shingu H, Ikata T, Katoh S, Akatsu T. Spinal injuries in Japan: a nationwide epidemiological survey in 1990. Paraplegia 1994; 32: 3-8.
7. Tator CH et al. Changes in epidemiology of acute spinal cord injury from 1947 to 1981. Surg Neurol 1993; 40: 207-215.
8. Barbeau H, Rossignol S. Enhancement of locomotor recovery following spinal cord injury. Curr Opin Neurol 1994; 7: 517-524.
9. Forssberg H, Grillner S. The locomotion of the acute spinal cat injected with clonidine i.v. Brain Res 1973; 50: 184-186.
10. Barbeau H, Rossignol S. Initiation and modulation of the locomotor pattern in the adult chronic spinal cat by noradrenergic serotonergic and dopaminergic drugs. Brain Res 1991; 546: 250-260.
11. Barbeau H, Julien C, Rossignol S. The effects of clonidine and yohimbine on locomotion and cutaneous reflexes in the adult chronic spinal cat. Brain Res 1987; 437: 83-96.
12. Barbeau H, Rossignol S. Recovery of locomotion after chronic spinalization in the adult cat. Brain Res 1987; 412: 84-95.
13. Rossignol S, Chau C, Barbeau H. Pharmacology of locomotion in chronic spinal cats. In: Taylor A, Gladden MH, Durbaba R (eds). Alpha and gamma motor systems. New York: Plenum Press, 1996, pp 449-455.
14. Stewart JE, Barbeau H, Cauthier S. Modulation of locomotor patterns and spasticity with clonidine in spinal cord injured patients. Can J Neurol Sci 1991; 18: 321-332.
15. Fedirchuk, B et al. Pharmacologically evoked fictive motor patterns in the acutely spinalized marmoset monkey (Callithrix jacchus). Exp Brain Res 1998; 122: 351-361.
16. Remy-Neris O et al. Effects of intrathecal clonidine injection on spinal reflexes and human locomotion in incomplete paraplegic subjects. Exp Brain Res 1999; 129: 433-440.
17. Dietz V, Colombo G, Jensen L, Baumgartner L. Locomotor capacity of spinal cord in paraplegic patients. Ann Neurol 1995; 37: 574-582.
18. Winter DA. Biomechanical motor patterns in normal walking. J Motor Behav 1983; 15: 302-330.
19. Norman KE, Barbeau H. Comparison of cyproheptadine, clonidine and baclofen on the modulation of gait pattern in subjects with spinal cord injury. In: Thilmann AR, Burke DJ, Rymer WZ (eds) Spasticity: Mechanisms and Management. Berlin: Springer-Verlag, 1993, pp 410-425.
20. Norman K, Pepin A, Barbeau H. Effects of drugs on walking after spinal cord injury Spinal Cord 1998; 36(10): 699-715.
21. Bastings E, Rapisarda G, Pepin JL, Delwaide PJ. Nouvelles approches pharmacologiques du traitement des troubles de la marche consecutifs à une lesion spinale. Rev Med Liège 1995; 50: 204-208.
22. Delwaide PJ, Pennisi G. Tizanidine and electrophysiologic analysis of spinal control mechanisms in humans with spasticity. Neurology 1994; 44 (suppl 9): S21-S27.
23. Knutsson E. Analysis of gait and isokinetic movements for evaluation of antispastic drugs or physical therapies. In: Desmedt JE (ed). Motor control mechanisms in health and disease. Advances in Neurology 39. New York: Raven Press, 1983, pp 1013-1034.
24. Fung J, Stewart JE, Barbeau H. The combined effects of clonidine and cyproheptadine with interactive training on the modulation of locomotion in spinal cord injured subjects. J Neurol Sci 1990; 100: 85-93.
25. Ladouceur M, Pepin A, Norman KE, Barbeau H. Recovery of walking after spinal cord injury. Adv Neurol 1997; 72: 249-255.
26. Gladstone DJ, Black SE. Enhancing recovery after stroke with noradrenergic pharmacotherapy: a new frontier? Can J Neurol Sci 2000; 27: 97-105.
27. Unwin H, Walker-Batson D. No side effects after low-dose amphetamine administration in stroke rehabilitation. Stroke 2000; 31: 1788-1789.